Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Edwards

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Chemmedchem|March 2, 2011
Revealing atropisomer axial chirality in drug discoverySteven R LaPlante, Paul J Edwards, Lee D Fader, et al.
Current Opinion in Drug Discovery & Development|August 8, 2006
Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leadsPaul J Edwards, Brigitte Allart, Martin J I Andrews, et al.
Journal of Dairy Science|September 13, 2025
Effects of management and technology scenarios on the carbon footprint of milk from pasture-based dairy farm systemsAndre M Mazzetto, Shelley Falconer, Paul J Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
The reversed binding of beta-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitorsSonja Nordhoff, Silvia Cerezo-Gálvez, Achim Feurer, et al.
Journal of Medicinal Chemistry|August 19, 2011
Assessing atropisomer axial chirality in drug discovery and developmentSteven R Laplante, Lee D Fader, Keith R Fandrick, et al.
Chemical Science|August 30, 2018
The creation and characterisation of a National Compound Collection: the Royal Society of Chemistry pilotDavid M Andrews, Laura M Broad, Paul J Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IVSonja Nordhoff, Silvia Cerezo-Gálvez, Holger Deppe, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2009
The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacementsSonja Nordhoff, Stephan Bulat, Silvia Cerezo-Gálvez, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IVSonja Nordhoff, Meritxell López-Canet, Barbara Hoffmann-Enger, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritisMartin J I Andrews, J Andrew Clase, Gregory Bar, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Chemmedchem|March 2, 2011
Revealing atropisomer axial chirality in drug discoverySteven R LaPlante, Paul J Edwards, Lee D Fader, et al.
Current Opinion in Drug Discovery & Development|August 8, 2006
Expediting drug discovery: recent advances in fast medicinal chemistry--optimization of hits and leadsPaul J Edwards, Brigitte Allart, Martin J I Andrews, et al.
Journal of Dairy Science|September 13, 2025
Effects of management and technology scenarios on the carbon footprint of milk from pasture-based dairy farm systemsAndre M Mazzetto, Shelley Falconer, Paul J Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2005
The reversed binding of beta-phenethylamine inhibitors of DPP-IV: X-ray structures and properties of novel fragment and elaborated inhibitorsSonja Nordhoff, Silvia Cerezo-Gálvez, Achim Feurer, et al.
Journal of Medicinal Chemistry|August 19, 2011
Assessing atropisomer axial chirality in drug discovery and developmentSteven R Laplante, Lee D Fader, Keith R Fandrick, et al.
Chemical Science|August 30, 2018
The creation and characterisation of a National Compound Collection: the Royal Society of Chemistry pilotDavid M Andrews, Laura M Broad, Paul J Edwards, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Discovery of beta-homophenylalanine based pyrrolidin-2-ylmethyl amides and sulfonamides as highly potent and selective inhibitors of dipeptidyl peptidase IVSonja Nordhoff, Silvia Cerezo-Gálvez, Holger Deppe, et al.
Bioorganic & Medicinal Chemistry Letters|October 17, 2009
The design of potent and selective inhibitors of DPP-4: optimization of ADME properties by amide replacementsSonja Nordhoff, Stephan Bulat, Silvia Cerezo-Gálvez, et al.
Bioorganic & Medicinal Chemistry Letters|July 7, 2009
From lead to preclinical candidate: optimization of beta-homophenylalanine based inhibitors of dipeptidyl peptidase IVSonja Nordhoff, Meritxell López-Canet, Barbara Hoffmann-Enger, et al.
Bioorganic & Medicinal Chemistry Letters|February 21, 2012
Discovery of a series of imidazopyrazine small molecule inhibitors of the kinase MAPKAPK5, that show activity using in vitro and in vivo models of rheumatoid arthritisMartin J I Andrews, J Andrew Clase, Gregory Bar, et al.
Pageof 3